Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.

Journal article

Thornhill JP. et al, (2024), Aids, 38, 679 - 688

Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses.

Journal article

Dijokaite-Guraliuc A. et al, (2023), Cell rep, 42

Analysis of broadly neutralising antibody resistance in adolescents and young people living with HIV

Conference paper

Zacharopoulou P. et al, (2023), Hiv medicine, 24, 35 - 35

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses.

Journal article

Murray SM. et al, (2022), Nat rev immunol, 1 - 13

A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117.

Journal article

Zacharopoulou P. et al, (2022), Curr opin hiv aids, 17, 352 - 358

An exploration of how broadly neutralizing antibodies might induce HIV remission: the 'vaccinal' effect.

Journal article

Tipoe T. et al, (2022), Curr opin hiv aids, 17, 162 - 170

Load More